What question did this study set out to answer?

The aim is to develop rejuvenated T cells from iPSCs to address T cell exhaustion in chronic infections and cancer.

Generation of therapeutic T cells from human induced pluripotent stem cells

View Full Paper

Ask AI

Bookmark

Authors

Review outlines methods for generating rejuvenated T cells from iPSCs, implying potential for effective cancer and infection treatments.

The aim is to develop rejuvenated T cells from iPSCs to address T cell exhaustion in chronic infections and cancer.
Established a platform for generating therapeutic T cells from iPSCs using xeno-free manufacturing protocols.
Employed advanced gene editing techniques for enhancing T cell functionality and reducing immunogenicity.
Focused on producing regulatory T cells for the management of autoimmune disorders and GvHD.
Successfully generated 'off-the-shelf' allogeneic therapeutic T cells with minimized risk of GvHD.
Integrative gene editing approaches led to higher targeting efficiency in T cells.
Identified challenges in clinical translation, including manufacturing scalability and immunogenicity.

Wang et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark